Keywords: angiotech, cleared, extend, paclitaxel, trial, ms, received

Angiotech cleared to extend paclitaxel trial in MS

Article | 29 November 2001

Print This

Angiotech has received clearance from the Health Canada TherapeuticProducts Directorate to extend, by another year, its study to assess the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in